VOGLIBOSE 0.2/0.3 MG ORO DISPERSIBLE TABLET

Product description

UNIQUE SELLING POINT
  • Voglibose scores over both Acarbose (Glucobay®) and Miglitol in terms of lesser side effects profile.
  • Voglibose an Alpha glucosidase inhibitor & has no major drug interaction.
  • Voglibose provides effective management of high postprandial• (after meals) blood glucose level where other treatments fail.
Read more

Specifications

Details Strenght:0.2/0.3mg
Categories Pharmaceutical PackagingDrug Delivery Systems
Sales markets East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from India
Measured In mg
Selling Points Product Performance

More products from Athena

View all our products (14)
VOGLIBOSE 0.2/0.3 MG ORO DISPERSIBLE TABLET

Contact information

Address

Telephone

Website

View all contact information
SACMI INNOVATION

SACMI INNOVATION

Discover Innovation with Softigel by Procaps

Discover Innovation with Softigel by Procaps

Discover Japan’s premier contract manufacturing organization.

Discover Japan’s premier contract manufacturing organization.

Datwyler Pharma Packaging

Datwyler Pharma Packaging

Your trusted end-to-end CDMO partner

Your trusted end-to-end CDMO partner